Skip to main content
. 2020 May 11;20:284. doi: 10.1186/s12884-020-02961-5

Table 1.

Characteristics of the study population

HIP (n = 22) Control (n = 28) P-value
Age (years) 29 (27.00–33.5) 28 (25–30) 0.082
Pre-BMI (kg/m2) 24.28 (22.33–28.38) 20.49 (19.14–22.48) 0.000
Pre-weight (kg) 62.75 (55–73.5) 52.5 (49.00–58.5) 0.001
Waist (cm) 92.5 (86–106.5) 83.5 (76.0–86.5) 0.000
Hip (cm) 101.5(93.5–105.25) 92.5 (88.0–96.75) 0.002
SBP (mmHg) 134 (117.75–142.75) 119 (106.25–126.75) 0.002
DBP (mmHg) 83 (72–92) 69.5 (61.0–80.5) 0.004
FBG (mmol/L) 5.64 (5.2–7.9) 4.36 (4.05–4.56) 0.000
TC (mmol/L) 4.17 (3.97–4.68) 4.45 (3.83–4.85) 0.83
TGs (mmol/L) 1.77 (1.45–3.23) 1.18 (1.03–1.61) 0.000
HDL (mmol/L) 1.25 (1.09–1.53) 1.86 (1.61–2.04) 0.000
LDL (mmol/L) 2.71 (2.27–3.12) 2.32 (1.89–2.67) 0.047
HbA1c (mmol/L) 6.55 (6.1–7.88) 5.1 (4.93–5.3) 0.000
CRP (mmol/L) 4.75 (2.68–9.43) 2.09 (0.95–3.49) 0.002
FINS (mIU/L) 9.15 (6.7–16.55)

Values are represented as medians (interquartile range). Differences were analysed using Mann-Whitney U tests. BMI Body mass index; SBP Systolic blood pressure; DBP Diastolic blood pressure; TC, total cholesterol; TGs, triglycerides; HDL, high-density lipoprotein; LDL Low-density lipoprotein; GLU Fasting blood glucose; FINS Fasting insulin